#1 Management expects execution to pick up in H2FY27, supported by a record order backlog
#2 Strong order momentum could drive inflows above FY27 guidance
#3 Growth opportunities in power electronics, EVs, industrial automation, AI factories, data centres and energy security capex
#4 AI factory and data centre capacity targeted to expand 10-fold
#5 Early wins include a $1.4 billion Nvidia AI factory project and the 500K Make in India EV motor
#6 New businesses could expand L&T's addressable market
#7 New businesses diversify growth drivers and strengthen its position across infrastructure and technology verticals
Larsen and Toubro was quoting at Rs 4,173.00, up Rs 17.50, or 0.42 percent.
It has touched an intraday high of Rs 4,185.00 and an intraday low of Rs 4,151.65.
It was trading with volumes of 20,314 shares, compared to its five day average of 218,209 shares, a decrease of -90.69 percent.
Signature Global said that a consortium led by its wholly owned subsidiary, Maa Vaishno Net-Tech, has emerged as the successful bidder for 474.66 acres of land in Raigad, Maharashtra, part of the Mumbai Metropolitan Region (MMR).
The consortium's bid for the land is valued at Rs 194.19 crore.
SignatureGlobal India was quoting at Rs 830.20, down Rs 5.40, or 0.65 percent.
It has touched an intraday high of Rs 868.95 and an intraday low of Rs 822.
It was trading with volumes of 63,373 shares, compared to its five day average of 34,818 shares, an increase of 82.01 percent.
The company has acquired an additional 4.59 percent partnership interest, directly and indirectly, in Prestige Vaishnaoi Projects by infusing Rs 110.93 crore.
Following this acquisition, Prestige Estates Projects now holds a combined 42.83 percent partnership interest in Prestige Vaishnaoi Projects, directly and indirectly.
Meanwhile, the company's subsidiary, Prestige Falcon Realty Ventures, has acquired a 50 percent stake in Advent Convention & Hotels International to develop a commercial project in Mumbai, with an estimated gross development value (GDV) of approximately Rs 4,500 crore.
Prestige Estates Projects was quoting at Rs 1,684.60, down Rs 6.90, or 0.41 percent.
It has touched an intraday high of Rs 1,691.70 and an intraday low of Rs 1,660.
It was trading with volumes of 3,862 shares, compared to its five day average of 19,277 shares, a decrease of -79.97 percent.
Kilburn Engineering was quoting at Rs 383.40, down Rs 10.80, or 2.74 percent.
It has touched an intraday high of Rs 391.30 and an intraday low of Rs 384.15.
It was trading with volumes of 1,021 shares, compared to its five day average of 82,279 shares, a decrease of -98.76 percent.
In the previous trading session, the share closed up 0.63 percent or Rs 2.45 at Rs 393.20.
The share touched a 52-week high of Rs 597.50 and a 52-week low of Rs 334.40 on 01 December, 2025 and 17 August, 2026, respectively.
Currently, the stock is trading 35.69 percent below its 52-week high and 14.91 percent above its 52-week low.
Market capitalisation stands at Rs 1,820.68 crore.
Biocon today announced that the European Commission (EC) has granted marketing authorization for Pebrilzo, its biosimilar pertuzumab, for the treatment of HER2-positive breast cancer across multiple disease stages in the European Union (EU).
Biocon’s pertuzumab biosimilar is the first biosimilar to receive EC marketing authorisation under the European Medicines Agency’s (EMA) new tailored clinical approach. This milestone follows its positive CHMP opinion on September 17, 2026.
Biocon was quoting at Rs 362.75, up Rs 3.35, or 0.93 percent.
It has touched an intraday high of Rs 361.35 and an intraday low of Rs 357.35.
It was trading with volumes of 14,410 shares, compared to its five day average of 256,788 shares, a decrease of -94.39 percent.
United States Food and Drug Administration (USFDA) has classified the inspection conducted between 19 October 2026 to 22 October 2026, at the manufacturing facility of InvaGen Pharmaceuticals Inc. (InvaGen), a wholly owned subsidiary of Cipla, located in Hauppauge, Long Island, New York, USA, as No Action Indicated (NAI).
Cipla was quoting at Rs 1,389.40, up Rs 1.40, or 0.10 percent.
It has touched an intraday high of Rs 1,391.50 and an intraday low of Rs 1,382.
It was trading with volumes of 2,500 shares, compared to its five day average of 149,288 shares, a decrease of -98.33 percent.
Brent crude has corrected sharply in November, falling over 13% in the first week and easing to around $91–92 per barrel, well below its recent peak of $130.8.
Crude prices have been driven more by geopolitics than by demand-supply fundamentals this year. Still, the latest decline reflects expectations of an imminent global supply surplus and recovering Middle Eastern exports outweighing the risks of stalled US–Iran talks.
Prices have since stabilised in a narrow $91–93 band, though the market remains highly headline-driven. Until there is a meaningful resolution to the Iran–US conflict, nothing can be predicted with certainty. For India, sustained lower crude would ease pressure on the import bill, inflation and the rupee, while a renewed spike would erode these.
The company has entered into a joint venture agreement with South Korean company DYA to design, manufacture and supply passenger car seats in India, primarily for Kia India and Hyundai India.
NDR Auto Components will hold a 51 percent stake in the proposed joint venture company, while DYA will own the remaining 49 percent.
NDR Auto Components was quoting at Rs 804.55, up Rs 83.25, or 11.54 percent.
It has touched an intraday high of Rs 808 and an intraday low of Rs 748.95.
It was trading with volumes of 19,547 shares, compared to its five day average of 919 shares, an increase of 2,026.06 percent.
The company has entered into a technology agreement with Italy-based Versalis S.p.A. for setting up a second production line with a capacity of 70 KTPA for mABS, entailing an investment of Rs 450 crore.
The proposed capacity is expected to be commissioned by December 2028.
Supreme Petrochem was quoting at Rs 698.50, up Rs 0.45, or 0.06 percent.
It has touched an intraday high of Rs 706.70 and an intraday low of Rs 690.30.
It was trading with volumes of 970 shares, compared to its five day average of 2,698 shares, a decrease of -64.05 percent.
Caplin Point Laboratories was quoting at Rs 2,092.80, down Rs 154.30, or 6.87 percent.
It has touched an intraday high of Rs 2,239 and an intraday low of Rs 2,090.
It was trading with volumes of 21,245 shares, compared to its five day average of 12,879 shares, an increase of 64.96 percent.
In the previous trading session, the share closed down 3.98 percent or Rs 93.35 at Rs 2,251.10.
The share touched a 52-week high of Rs 2,990.60 and a 52-week low of Rs 1,502.45 on 24 September, 2026 and 30 March, 2026, respectively.
Currently, the stock is trading 29.94 percent below its 52-week high and 39.45 percent above its 52-week low.
Market capitalisation stands at Rs 15,907.73 crore.
The company has acquired an additional 4.59 percent partnership interest, directly and indirectly, in Prestige Vaishnaoi Projects by infusing Rs 110.93 crore.
Following this acquisition, Prestige Estates Projects now holds a combined 42.83 percent partnership interest in Prestige Vaishnaoi Projects, directly and indirectly.
Meanwhile, the company's subsidiary, Prestige Falcon Realty Ventures, has acquired a 50 percent stake in Advent Convention & Hotels International to develop a commercial project in Mumbai, with an estimated gross development value (GDV) of approximately Rs 4,500 crore.
Prestige Estates Projects was quoting at Rs 1,664.20, down Rs 27.30, or 1.61 percent.
It has touched an intraday high of Rs 1,688.00 and an intraday low of Rs 1,660.
It was trading with volumes of 2,659 shares, compared to its five day average of 19,277 shares, a decrease of -86.21 percent.
Swan Corp was quoting at Rs 231.93, up Rs 1.70, or 0.74 percent.
It has touched an intraday high of Rs 248.35 and an intraday low of Rs 232.80.
It was trading with volumes of 102,722 shares, compared to its five day average of 55,762 shares, an increase of 84.21 percent.
In the previous trading session, the share closed up 0.74 percent or Rs 1.70 at Rs 230.65.
The share touched a 52-week high of Rs 493.70 and a 52-week low of Rs 222.25 on 29 December, 2025 and 30 October, 2026, respectively.
Currently, the stock is trading 52.8 percent below its 52-week high and 4.86 percent above its 52-week low.
Market capitalisation stands at Rs 7,270.01 crore.




